Author:
Tsui Wai-King,Yip Yuk-Chiu,Yip Ka-Huen
Abstract
Non-invasive prenatal testing (NIPT) demonstrates superior performance compared to conventional screening methods currently available within Hong Kong’s public healthcare system. Nevertheless, the substantial costs associated with NIPT render it inaccessible for much of the population, leading to ethical debates surrounding public funding. A conflict emerges between the imperative to allocate limited resources efficiently and the obligation to uphold ethical principles of equity and reproductive autonomy within the public healthcare system. Adopting a utilitarian-based approach, this chapter initially presents three central arguments suggesting that NIPT can be ethically integrated into the public healthcare system. Subsequently, the discussion examines the challenges associated with incorporating NIPT into Hong Kong’s strained public healthcare system. To address these challenges, we propose two potential solutions: (1) introducing NIPT as a second-tier screening test for high-risk pregnancies, or (2) offering NIPT through public-private partnerships, which would alleviate the demand on public sector resources. Implementing a nominal fee for NIPT adheres to the principle of impartiality in public resource allocation, ensuring equitable decision-making without favoring specific population groups. Ultimately, the future of NIPT in Hong Kong necessitates expanding its availability, enhancing its accuracy, and incorporating it into comprehensive prenatal care. This approach will support the reproductive autonomy of pregnant women and promote accessible healthcare.
Reference36 articles.
1. Mazloom AR, Džakula Ž, Oeth P, Wang H, Jensen T, Tynan J, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenatal Diagnosis. 2013;:591-597. DOI: 10.1002/pd.4127
2. Savva GM, Walker K, Morris JK. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome). Prenatal Diagnosis: Published in Affiliation with the International Society for Prenatal Diagnosis. 2010;(1):57-64. DOI: 10.1002/pd.2403
3. Yi H, Hallowell N, Griffiths S, Yeung LT. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: A qualitative study with early adopter patients in Hong Kong. PLoS One. 2013;(11):e81794. DOI: 10.1371/journal.pone.0081794
4. Benitez MA. Hong Kong’s public hospitals to offer non-invasive Down’s syndrome test for free to women with high-risk pregnancies [Internet]. South China Morning Post. 2018. Available from: [Accessed: January 22, 2023]
5. Yip YC, Tsui WK. Ethical considerations for offering non-invasive prenatal tests within a public healthcare system: A rule utilitarian perspective. Ethics & Medicine. 2020;(2):101-167